Abstract
Advancements in blood group typing techniques are pivotal in improving blood bank operations and patient care. These techniques, spanning serological and molecular methods, have revolutionized transfusion medicine. Serological typings reliability, using hemagglutination reactions against specific antisera, remains key for blood compatibility assessment. However, time constraints and limited rare variant detection have driven molecular methods evolution, such as PCR and DNA sequencing. These offer accuracy, rapidity, and rare variant identification. Such innovations have overhauled blood bank operations, enabling effective transfusion matching, reducing reactions, and enhancing outcomes. They have streamlined donor screening, optimized rare type use, and eased organ transplant compatibility testing. Despite challenges like cost and standardization, advancements in point-of-care devices, AI algorithms, and personalized medicine promise further enhancements. These advances ensure safer, efficient blood transfusion practices.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
